Bukhari Syed Ibrahim, Arega Gashaw, Altaf Sadaf
Department of Oncology, Aga Khan University, Karachi, Pakistan.
Division of Hematology Oncology, Department of Pediatrics & Child Health, Addis Ababa University, Addis Ababa, Ethiopia.
Discov Oncol. 2024 Sep 8;15(1):415. doi: 10.1007/s12672-024-01209-4.
Most newly diagnosed pediatric cancer patients reside in LMICs. These countries face challenges in providing quality treatment, particularly with procedures requiring stillness or causing pain. Conscious sedation (CS) is underutilized in LMICs due, causing treatment delays and adverse outcomes. Advocacy for CS teams, training, and policy support is essential to improve outcomes.
大多数新诊断出的儿科癌症患者居住在低收入和中等收入国家。这些国家在提供高质量治疗方面面临挑战,尤其是对于需要保持静止或会引起疼痛的治疗程序。在低收入和中等收入国家,清醒镇静(CS)的使用不足,导致治疗延误和不良后果。倡导成立清醒镇静团队、开展培训并提供政策支持对于改善治疗效果至关重要。